MedIntelliBase
Your current "Economic Issues in U.S. Healthcare" Breaking News as of April 8, 2010
  • Scrolling View
  • Listed View
  • Subscribe

  • MedIntelliBlog
    proven intelligence solutions

    WeirdMedicalTM...
    anomalies for strange times

    MedIntelliBase:
    3-week free trial - pick your topic
    Most Read Abstracts of Last Week...
    Survey Finds 'The Need for Change' in Healthcare System a Major Driver in Strong Public Support
    Obesity, Fitness & Wellness Week, 2010-04-10
    "The historic vote in favor of health reform by the House of Representatives on March 21, is being widely communicated to be either one the most positive for public..."
    Drug lobby's big win with health care reform
    The Seattle Times, 2010-03-29
    "Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama's health care law..."
    R&D Investment by U.S. Biopharmaceutical Companies Increases to Record $65.3 Billion, Study Finds
    Biotech Week, 2010-03-31
    "New research just released reveals that research & development (R&D) investment in new medicines and vaccines by the U.S. biopharmaceutical industry was $65.3 billion in 2009, an increase of..."
    Scientist: FDA suppressed imaging safety concerns
    Associated Press via The Seattle Times, 2010-03-30
    "A former Food and Drug Administration scientist said Tuesday his job was eliminated after he raised concerns about the risks of radiation exposure from high-grade medical scanning..."

    If you have any questions or comments about this service we welcome your feedback.

    Best regards -

    Jordan & Vicky


    Jordan Zornes
        -- Editor & Senior Analyst | Phone 1-425.894.4147 | jpz@medintellibase.com

    Vicky Hunsicker Sanko
        -- Senior Editor, President & CEO | Office Phone – 1-425-869-8724 – Mobile Phone – 1-206-669-3053| vhs@medintellibase.com



    *, ® - "The Next Phase" and "MedIntelliBase" are registered trademarks of The Next Phase Consultancy, Inc.